Showing 21 - 40 results of 131 for search '"molecular oncology"', query time: 0.05s Refine Results
  1. 21
    ERK1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility

    ERK1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility by Dalia de laFuente‐Vivas, Vincenzo Cappitelli, Rocío García‐Gómez, Sara Valero‐Díaz, Camilla Amato, Javier Rodriguéz, Santiago Duro‐Sánchez, Alexander vonKriegsheim, Michael Grusch, José Lozano, Joaquín Arribas, Berta Casar, Piero Crespo

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 22
    Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway

    Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway by Adrish Sen, Salmaan Khan, Stefano Rossetti, Aaron Broege, Ian MacNeil, Ann DeLaForest, Jhomary Molden, Laura Davis, Charles Iversrud, Megan Seibel, Ross Kopher, Stephen Schulz, Lance Laing

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 23
    Platelet‐activating factor: a potential therapeutic target to improve cancer immunotherapy

    Platelet‐activating factor: a potential therapeutic target to improve cancer immunotherapy by Qi Yan, Hemn Mohammadpour

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 24
    CT45A1‐mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell‐in‐cell structure, potentiating the progression of microsatellite instability‐high colorectal cancer

    CT45A1‐mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell‐in‐cell structure, potentiating the progression of microsatellite... by Hao‐Wei Teng, Hsiang‐Yueh Huang, Chun‐Chi Lin, Yuh‐Ching Twu, Wen‐Hao Yang, Wen‐Chun Lin, Hsin‐Yi Lan, Yen‐Yu Lin, Wei‐Lun Hwang

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 25
    Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways

    Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways by Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise‐Lotte Flage‐Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 26
    A method to quantitatively characterize the formation and dissociation of tumor cell clusters using light transmission aggregometry

    A method to quantitatively characterize the formation and dissociation of tumor cell clusters using light transmission aggregometry by Regina Komal Kottana, Brian Schnoor, Anne‐Laure Papa

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 27
    MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives

    MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives by Michael Karin, Ju Youn Kim

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 28
    ENL mutation and AML: a new model that reveals oncogenic condensate's function in leukemogenesis

    ENL mutation and AML: a new model that reveals oncogenic condensate's function in leukemogenesis by Zhong Fan, Yanan Jiang, Xiaotian Zhang

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 29
    Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors

    Enhancing immunotherapy through PD‐L1 upregulation: the promising combination of anti‐PD‐L1 plus mTOR inhibitors by Anna Hernández‐Prat, Alejo Rodriguez‐Vida, Laura Cardona, Mengjuan Qin, Oriol Arpí‐Llucià, Luis Soria‐Jiménez, Sílvia Menendez, Fabricio Gerel Quimis, Miguel Galindo, Edurne Arriola, Marta Salido, Nuria Juanpere‐Rodero, Federico Rojo, Aura Muntasell, Joan Albanell, Ana Rovira, Joaquim Bellmunt

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 30
    Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression

    Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression by Elisa Carouge, Clémence Burnichon, Martin Figeac, Shéhérazade Sebda, Nathalie Vanpouille, Audrey Vinchent, Marie‐José Truong, Martine Duterque‐Coquillaud, David Tulasne, Anne Chotteau‐Lelièvre

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 31
    Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2

    Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2 by Satoru Miyazaki, Masato Kitazawa, Satoshi Nakamura, Makoto Koyama, Yuta Yamamoto, Nao Hondo, Masahiro Kataoka, Hirokazu Tanaka, Michiko Takeoka, Daisuke Komatsu, Yuji Soejima

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 32
    Detection of colorectal‐cancer‐associated bacterial taxa in fecal samples using next‐generation sequencing and 19 newly established qPCR assays

    Detection of colorectal‐cancer‐associated bacterial taxa in fecal samples using next‐generation sequencing and 19 newly established qPCR assays by Thulasika Senthakumaran, Tone M. Tannæs, Aina E. F. Moen, Stephan A. Brackmann, David Jahanlu, Trine B. Rounge, Vahid Bemanian, Hege S. Tunsjø

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 33
    The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K–AKT pathway

    The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K–AKT pathway by Xiaopei Shen, Jie Tan, Rengyun Liu, Guangwu Zhu, Lisa Rooper, Mingzhao Xing

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 34
    Simultaneous detection of eight cancer types using a multiplex droplet digital PCR assay

    Simultaneous detection of eight cancer types using a multiplex droplet digital PCR assay by Isabelle Neefs, Nele De Meulenaere, Thomas Vanpoucke, Janah Vandenhoeck, Dieter Peeters, Marc Peeters, Guy Van Camp, Ken Op de Beeck

    Published 2025-01-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 35
    When molecular biology transforms clinical oncology: the EGFR journey in colorectal cancer

    When molecular biology transforms clinical oncology: the EGFR journey in colorectal cancer by Pietro Paolo Vitiello, Nadia Saoudi González, Alberto Bardelli

    Published 2025-02-01
    “…Molecular Oncology…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 36
    CHAMP1 premature termination codon mutations found in individuals with intellectual disability cause a homologous recombination defect through haploinsufficiency

    CHAMP1 premature termination codon mutations found in individuals with intellectual disability cause a homologous recombination defect through haploinsufficiency by Yujiro Yoshizaki, Yunosuke Ouchi, Dicky Kurniawan, Eisuke Yumoto, Yuki Yoneyama, Faiza Ramadhani Rizqullah, Hiyori Sato, Mirjam Hanako Sarholz, Toyoaki Natsume, Masato T. Kanemaki, Masanori Ikeda, Ayako Ui, Kenji Iemura, Kozo Tanaka

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 37
    The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival

    The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival by Anna G. Antonacopoulou, Konstantina Floratou, Vasiliki Bravou, Anastasia Kottorou, Fotinos-Ioannis Dimitrakopoulos, Stella Marousi, Michalis Stavropoulos, Agelos K. Koutras, Chrisoula D. Scopa, Haralabos P. Kalofonos

    Published 2010-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 38
    Retraction Note: Association between cytochrome P4501A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysis

    Retraction Note: Association between cytochrome P4501A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysis by Fan-dong Meng, Ping Ma, Cheng-guang Sui, Xin Tian, You-hong Jiang

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 39
    Insights into expression and localization of HPV16 LCR-associated transcription factors and association with LCR activity in HNSCC

    Insights into expression and localization of HPV16 LCR-associated transcription factors and association with LCR activity in HNSCC by Nikita Aggarwal, Divya Janjua, Apoorva Chaudhary, Udit Joshi, Tanya Tripathi, Chetkar Chandra Keshavam, Joni Yadav, Arun Chhokar, Alok Chandra Bharti

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 40
    Cyclin-dependent protein kinases and cell cycle regulation in biology and disease

    Cyclin-dependent protein kinases and cell cycle regulation in biology and disease by Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, Ilenia Segatto, Valentina Rossi, Nicole Crestan, Javad Karimbayli, Barbara Belletti, Gustavo Baldassarre

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: